Related Experiment Video

Updated: Aug 7, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

[Sustained virological response in children with chronic hepatitis C treated with interferon alpha and ribavirin]

Teresa Woźniakowska-Gesicka1, Joanna Kupś, Małgorzata Wiśniewska-Ligier

  • 1III Klinika Pediatrii, Instytutu Centrum Zdrowia Matki Polki w Lodzi. IIIKlinikaPed@pharmanet.com.pl

Przeglad Lekarski
|June 22, 2006
PubMed

Insights

Combined therapy with interferon alfa (IFN-alpha) and ribavirine achieved a sustained virological response in 56% of children with chronic hepatitis C. Recurrence of hepatitis C virus infection was observed in 16% of cases, with notable side effects.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Virology

Background:

  • Chronic hepatitis C is a significant health concern in children.
  • Effective and safe treatment options for pediatric chronic hepatitis C are crucial.

Purpose of the Study:

  • To evaluate the efficacy and safety of combined interferon alfa (IFN-alpha) and ribavirine therapy in children with chronic hepatitis C.
  • To assess sustained virological response (SVR) rates and identify treatment-related side effects.

Main Methods:

  • A cohort of 37 children (aged 4-18 years) with chronic hepatitis C received 12 months of combined IFN-alpha and ribavirine treatment.
  • Hepatitis C virus (HCV) RNA levels were monitored at multiple time points, including early virological response (EVR), end of treatment (ETR), and sustained virological response (SVR).
  • Liver biopsies and regular blood tests (ALT, hemoglobin, leukocytes, platelets) were performed to assess disease status and monitor for side effects.

Main Results:

  • A sustained virological response (SVR) was achieved in approximately 56% (21 out of 37) of the treated children.
  • Early virological response (EVR) was observed in 25 children, with 21 achieving SVR.
  • HCV RNA elimination was not achieved in 12 children who did not achieve EVR.
  • A recurrence rate of 16% was noted after treatment completion.
  • Numerous side effects were observed during treatment, necessitating modifications in some cases.

Conclusions:

  • Twelve-month combined IFN-alpha and ribavirine therapy is effective in achieving sustained virological response in about 56% of pediatric patients with chronic hepatitis C.
  • The recurrence rate of HCV infection in children treated with this regimen is approximately 16%.
  • The combined therapy is associated with numerous side effects, requiring careful monitoring and potential treatment adjustments.
Abstract

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...